Tradewinds Capital Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-77
Closed -$6.72K – 684
2025
Q2
$6.72K Hold
77
– – ﹤0.01% 386
2025
Q1
$5.26K Hold
77
– – ﹤0.01% 414
2024
Q4
$5.99K Hold
77
– – ﹤0.01% 418
2024
Q3
$5.16K Hold
77
– – ﹤0.01% 404
2024
Q2
$8.73K Hold
77
– – ﹤0.01% 347
2024
Q1
$10.7K Hold
77
– – ﹤0.01% 311
2023
Q4
$9.55K Hold
77
– – ﹤0.01% 252
2023
Q3
$7.18K Hold
77
– – ﹤0.01% 260
2023
Q2
$9.9K Buy
+77
New +$9.31K ﹤0.01% 233
2020
Q4
– Sell
-60
Closed -$6K – 691
2020
Q3
$6K Buy
+60
New +$6.27K ﹤0.01% 457

Other funds holding DXCM

Tradewinds Capital Management's DXCM Position: Q3 2025 in Review

Tradewinds Capital Management sold out of DexCom (DXCM) in Q3 2025, closing a stake of 77 shares — an estimated $6.72K sold.

Tradewinds Capital Management first reported a position in DXCM in Q3 2020 and held it in 10 quarters. The position peaked at $10.7K in Q1 2024. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Tradewinds Capital Management reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Tradewinds Capital Management sold 77 DexCom shares in Q3 2025, an estimated $6.72K.
  • Tradewinds Capital Management first reported a position in DexCom in Q3 2020 and held it in 10 quarters.
  • Tradewinds Capital Management's DexCom position peaked at $10.7K in Q1 2024.
  • 911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Tradewinds Capital Management's 13F filing for Q3 2025, filed 21 Oct 2025.